Molecular image–guided surgery in gynaecological cancer: where do we stand?

Giusi Pisano, Thomas Wendler, Renato A. Valdés Olmos, Giorgia Garganese, Daphne D.D. Rietbergen, Francesco Giammarile, Sergi Vidal-Sicart, Maaike H.M. Oonk, Michael Frumovitz, Nadeem R. Abu-Rustum, Giovanni Scambia, Vittoria Rufini, Angela Collarino

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose: The aim of this review is to give an overview of the current status of molecular image–guided surgery in gynaecological malignancies, from both clinical and technological points of view. Methods: A narrative approach was taken to describe the relevant literature, focusing on clinical applications of molecular image–guided surgery in gynaecology, preoperative imaging as surgical roadmap, and intraoperative devices. Results: The most common clinical application in gynaecology is sentinel node biopsy (SNB). Other promising approaches are receptor-target modalities and occult lesion localisation. Preoperative SPECT/CT and PET/CT permit a roadmap for adequate surgical planning. Intraoperative detection modalities span from 1D probes to 2D portable cameras and 3D freehand imaging. Conclusion: After successful application of radio-guided SNB and SPECT, innovation is leaning towards hybrid modalities, such as hybrid tracer and fusion of imaging approaches including SPECT/CT and PET/CT. Robotic surgery, as well as augmented reality and virtual reality techniques, is leading to application of these innovative technologies to the clinical setting, guiding surgeons towards a precise, personalised, and minimally invasive approach.

Original languageEnglish (US)
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
DOIs
StateAccepted/In press - 2024

Keywords

  • Gynaecological cancers
  • Hybrid tracer
  • Image-guided surgery
  • Robotic surgery
  • Sentinel node biopsy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Molecular image–guided surgery in gynaecological cancer: where do we stand?'. Together they form a unique fingerprint.

Cite this